Hematology Diagnostics Market: By Testing Product (Instruments, Consumables, Controls & Calibrators, Others), By Test Type (Blood count, Platelet function & Clotting, Hemoglobin, Hematocrit, Bone Marrow Biopsy), By End User (Hospital, Diagnostic labs, Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

1. Executive Summary
2. Global Hematology Diagnostics Market Introduction
2.1. Global Hematology Diagnostics Market – Taxonomy
2.2. Global Hematology Diagnostics Market –Definitions
2.2.1. By Testing Product
2.2.2. By Test Type
2.2.3. By End User
2.2.4. By Region
3. Global Hematology Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Hematology Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Hematology Diagnostics Market – Competition Landscape
4. Global Hematology Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Hematology Diagnostics Market, By Testing Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Fully Automated Analyzers
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Semi-Automated Analyzers
5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Flow cytometers
5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Others
5.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.2. Consumables
5.2.1. Reagents
5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Stains
5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Controls & Calibrators
5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.2.4. Others
5.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4.3. Market Opportunity Analysis
6. Global Hematology Diagnostics Market Forecast, By Test Type, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Blood count
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Platelet function & Clotting
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Hemoglobin
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Hematocrit
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Bone Marrow Biopsy
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. global Hematology Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospital
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic labs
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Hematology Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Region, 2022-2028
9. North America Hematology Diagnostics market analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Instruments
9.1.1.1. Fully Automated Analyzers
9.1.1.2. Semi-Automated Analyzers
9.1.1.3. Flow cytometers
9.1.1.4. Others
9.1.2. Consumables
9.1.2.1. Reagents
9.1.2.2. Stains
9.1.2.3. Controls & Calibrators
9.1.2.4. Others
9.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Blood count
9.2.2. Platelet function & Clotting
9.2.3. Hemoglobin
9.2.4. Hematocrit
9.2.5. Bone Marrow Biopsy
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospital
9.3.2. Diagnostic labs
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028
9.6. North America Hematology Diagnostics Market Dynamics – Trends
10. Europe Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.1.1. Fully Automated Analyzers
10.1.1.2. Semi-Automated Analyzers
10.1.1.3. Flow cytometers
10.1.1.4. Others
10.1.2. Consumables
10.1.2.1. Reagents
10.1.2.2. Stains
10.1.2.3. Controls & Calibrators
10.1.2.4. Others
10.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Blood count
10.2.2. Platelet function & Clotting
10.2.3. Hemoglobin
10.2.4. Hematocrit
10.2.5. Bone Marrow Biopsy
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospital
10.3.2. Diagnostic labs
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Hematology Diagnostics Market - Opportunity Analysis Index, By  Testing Product, Test Type, End User, and Country, 2022-2028
10.6. Europe Hematology Diagnostics Market Dynamics – Trends
11. Asia-Pacific Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.1.1. Fully Automated Analyzers
11.1.1.2. Semi-Automated Analyzers
11.1.1.3. Flow cytometers
11.1.1.4. Others
11.1.2. Consumables
11.1.2.1. Reagents
11.1.2.2. Stains
11.1.2.3. Controls & Calibrators
11.1.2.4. Others
11.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Blood count
11.2.2. Platelet function & Clotting
11.2.3. Hemoglobin
11.2.4. Hematocrit
11.2.5. Bone Marrow Biopsy
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospital
11.3.2. Diagnostic labs
11.3.3. Others
11.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Hematology Diagnostics Market - Opportunity Analysis Index, By  Testing Product, Test Type, End User, and Country, 2022-2028
11.6. Asia-Pacific Hematology Diagnostics Market Dynamics – Trends
12. Latin America Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.1.1. Fully Automated Analyzers
12.1.1.2. Semi-Automated Analyzers
12.1.1.3. Flow cytometers
12.1.1.4. Others
12.1.2. Consumables
12.1.2.1. Reagents
12.1.2.2. Stains
12.1.2.3. Controls & Calibrators
12.1.2.4. Others
12.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Blood count
12.2.2. Platelet function & Clotting
12.2.3. Hemoglobin
12.2.4. Hematocrit
12.2.5. Bone Marrow Biopsy
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospital
12.3.2. Diagnostic labs
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028
12.6. Latin America Hematology Diagnostics Market Dynamics – Trends
13. Middle East and Africa Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.1.1. Fully Automated Analyzers
13.1.1.2. Semi-Automated Analyzers
13.1.1.3. Flow cytometers
13.1.1.4. Others
13.1.2. Consumables
13.1.2.1. Reagents
13.1.2.2. Stains
13.1.2.3. Controls & Calibrators
13.1.2.4. Others
13.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Blood count
13.2.2. Platelet function & Clotting
13.2.3. Hemoglobin
13.2.4. Hematocrit
13.2.5. Bone Marrow Biopsy
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospital
13.3.2. Diagnostic labs
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028
13.6. MEA Hematology Diagnostics Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Test Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Sysmex
14.2.2. Danaher
14.2.3. Nihon Kohden
14.2.4. Siemens
14.2.5. Abbott Laboratories
14.2.6. Boule Diagnostics
14.2.7. HORIBA
14.2.8. Bio-Rad Laboratories
14.2.9. BioSystems
14.2.10. Diatron
14.2.11. Roche
15. Research Methodology
16. Key Assumptions and Acronyms

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

 
  • Sysmex
  • Danaher
  • Nihon Kohden
  • Siemens
  • Abbott Laboratories
  • Boule Diagnostics
  • HORIBA
  • Bio-Rad Laboratories
  • BioSystems
  • Diatron
  • Roche

Adjacent Markets